NEPT — Stock Film
STOCK FILMSCENE 1/12NEPT · $0.20
Stock Expert AI presents
NEPT
Neptune Wellness Solutions Inc
~5 min film100% real numbersplain English
WHAT DOES THIS COMPANY DO?
Neptune Wellness Solutions Inc. What it actually does.

Develops and markets lifestyle brands and consumer packaged goods. Offers turnkey product development and supply chain solutions. Now — the numbers.

on the stock market since 2007
50 employees
$857K market value
WHERE DOES THE MONEY COME FROM?
36%Nutraceutical Products
Nutraceutical ProductsInnovation Products 32%Processing Services 25%Food and Beverages Products 7%Cannabis and Hemp Products 1%
36% of all revenue comes from a single line: Nutraceutical Products.

Revenue is spread across several lines; no single product carries the company.

Revenue last year:
$52.6M
The loss that same year:
$81.7M
For every $1 it earns, the company spends $3.

The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.

THE SALES TREND
Sales are growing, year after year.

Average growth of 30% a year over the last 4 years. Red columns mark years that ended in a loss.

$18.3M
2019
2020
2021
2022
$52.6M
2023
In the vault right now:
$2M
DEBT: $25.3M
At this pace, that money lasts less than a year.

Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.

Every quarter, analysts set a profit bar.
How many of the last 8 did the company clear?
2 / 8
EXPECTATIONS MET OR BEATEN
2
Feb 2020
Jul 2022
2 TIMES IN THE LAST 8 QUARTERS
It misses the bar more often than not.
What executives did with their own stock over the last 12 months:
8 buy23 sell

Executive selling isn’t always bad news; people sell for personal reasons too. Still, the thin buying side is worth noting.

THE FIVE-YEAR JOURNEY
A long and steep decline.

An investor who bought at the very peak is down 100% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

1
THE BRIGHT SIDE · 1/2
Sales keep climbing

Over the last 4 years, sales grew about 30% a year on average.

2
THE BRIGHT SIDE · 2/2
The product is selling

Sales run at $52.6M a year. A small number, but proof the product has real buyers.

1
THE RISKS · 1/3
Small sales, big loss

A loss of $81.7M against $52.6M in annual sales.

2
THE RISKS · 2/3
Trading under $1

The stock sits at $0.20. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.

3
THE RISKS · 3/3
A wildly swinging price

This stock swings about 2.2 times as much as the market average. Big rallies — and big drops — can both happen fast.

FINALE · THE GRADE
grade pending

We don’t have a report card for this stock yet — the data isn’t mature enough to grade. No grade is information too: it means the evidence is thin.

One-line summary: few numbers, an untested story. Keep watching.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Sep 11, 2026 · stockexpertai.com · Stock Film